INVA
Innoviva, Inc.
$22.74
+1.34%
$1.7B
No data for this timeframe.
Vol
Market Cap$1.7B
Cap SizeSmall Cap
Analyst ConsensusStrong Buy (82%)
Inst. Holders50 funds
Inst. Value$1.2B
Inst. Activity19 buys / 9 sells
Reddit Sentiment67° Warm
SEC Reports3
Recent Activity
May 22, 2026
short_volume
Short Volume: INVA — 82.1% short (0.6M / 0.7M)
Short: 589,297 | Exempt: 223,800 | TRF Vol: 717,911 | Short Ratio: 82.1% | Off-exchange volume (dark
May 20, 2026
Insider
Raifeld Pavel surrendered for taxes 1,130 shares
Chief Executive Officer @ $22.24 ($25.1K)
May 20, 2026
Insider
Zhen Marianne surrendered for taxes 1,127 shares
Chief Accounting Officer @ $22.24 ($25.1K)
May 20, 2026
Insider
Basso Stephen surrendered for taxes 559 shares
Chief Financial Officer @ $22.24 ($12.4K)
May 18, 2026
SEC
Innoviva reported the resignations of board members Derek Small and Mark DiPaolo to focus on their roles at Syndeio BioS
8-K — Impact 3/10
May 6, 2026
SEC
Innoviva reported Q1 2026 total revenue of $98.0M (+11% YoY, slightly below $101.6M consensus) and diluted EPS of $2.22,
8-K — Impact 5/10
Mar 27, 2026
SEC
Innoviva, Inc. filed an amended 10-K to include the audited consolidated financial statements of its majority-owned subs
10-K/A — Impact 3/10
Inst.
DZ BANK AG Deutsche — ADD
892,336 shares ($20.8M)
Price Targets
$35.50
+56.1% upside
Strong Buy
Current $22.74
Low $18.00
Median $39.00
High $46.00
4 analysts
$18.00
$46.00
Analyst Ratings
4Strong Buy
5Buy
1Hold
1Sell
0Strong Sell
Recent Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Jun 1, 2026 | HC Wainwright & Co. | REITERATE | Buy → Buy |
| May 26, 2026 | BTIG | REITERATE | Buy → Buy |
| May 7, 2026 | BTIG | MAINTAIN | Buy → Buy |
| Feb 26, 2026 | BTIG | REITERATE | Buy → Buy |
| Feb 17, 2026 | BTIG | INITIATE | Buy |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $0.50 | $0.50 — $0.50 | 1 | |
| Next Q | $0.46 | $0.46 — $0.46 | 20% YoY | 1 |
| Current FY | $1.91 | $1.91 — $1.91 | 2% YoY | 1 |
| Next FY | $2.21 ▼ -3.3% | $2.21 — $2.21 | 16% YoY | 1 |
Latest Reports
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| BlackRock, Inc. | $263.5M | — |
| DIMENSIONAL FUND ADVISORS LP | $103.4M | — |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $98.4M | — |
| RENAISSANCE TECHNOLOGIES LLC | $94.5M | — |
| VANGUARD CAPITAL MANAGEMENT LLC | $73.2M | — |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| May 20, 2026 | Raifeld Pavel | F | $25.1K |
| May 20, 2026 | Zhen Marianne | F | $25.1K |
| May 20, 2026 | Basso Stephen | F | $12.4K |
| May 18, 2026 | Linden Josephine | A | $0.00 |
| May 18, 2026 | Linden Josephine | A | $0.00 |
Reddit Sentiment
67°
Warm
Bearish
Neutral
Bullish
50 institutional holders with $1.2B total value (52,867,765 shares) as of 2026-Q1. Top holders: BlackRock,, DIMENSIONAL, VANGUARD. Net buying activity: 19 institutions added/increased vs 9 reduced.
Top Institutional Holders — 2026-Q1
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 11,307,845 | $263.5M | 21.4% | — |
| 2 | DIMENSIONAL FUND ADVISORS LP | 4,436,427 | $103.4M | 8.4% | — |
| 3 | VANGUARD PORTFOLIO MANAGEMENT LLC | 4,224,951 | $98.4M | 8.0% | — |
| 4 | RENAISSANCE TECHNOLOGIES LLC | 4,055,632 | $94.5M | 7.7% | — |
| 5 | VANGUARD CAPITAL MANAGEMENT LLC | 3,141,581 | $73.2M | 5.9% | — |
| 6 | STATE STREET CORP | 3,060,377 | $71.3M | 5.8% | — |
| 7 | ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 1,887,570 | $44.0M | 3.6% | — |
| 8 | BANK OF AMERICA CORP /DE/ | 1,619,994 | $37.7M | 3.1% | — |
| 9 | GOLDMAN SACHS GROUP INC | 1,593,383 | $37.1M | 3.0% | — |
| 10 | MARSHALL WACE, LLP | 1,504,411 | $35.1M | 2.8% | — |
| 11 | TWO SIGMA INVESTMENTS, LP | 1,484,264 | $34.6M | 2.8% | ADD +60.8% |
| 12 | MORGAN STANLEY | 1,310,750 | $30.5M | 2.5% | — |
| 13 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1,163,713 | $27.1M | 2.2% | — |
| 14 | ROYCE & ASSOCIATES LP | 1,061,448 | $24.7M | 2.0% | ADD +81.9% |
| 15 | DEUTSCHE BANK AG\ | 908,067 | $21.2M | 1.7% | — |
| 16 | Invesco Ltd. | 904,282 | $21.1M | 1.7% | — |
| 17 | DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 892,336 | $20.8M | 1.7% | ADD +28.0% |
| 18 | Nuveen, LLC | 620,482 | $14.5M | 1.2% | TRIM -53.5% |
| 19 | WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 574,825 | $13.4M | 1.1% | NEW |
| 20 | VICTORY CAPITAL MANAGEMENT INC | 523,415 | $12.2M | 1.0% | ADD +42.2% |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | ADD | 696,911 | 892,336 | +28.0% | $20.8M | 2026-Q1 |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | NEW | — | 574,825 | — | $13.4M | 2026-Q1 |
| VICTORY CAPITAL MANAGEMENT INC | ADD | 368,000 | 523,415 | +42.2% | $12.2M | 2026-Q1 |
| Allianz Asset Management GmbH | ADD | 336,904 | 519,017 | +54.1% | $12.1M | 2026-Q1 |
| BALYASNY ASSET MANAGEMENT L.P. | ADD | 244,030 | 322,009 | +32.0% | $7.5M | 2026-Q1 |
| FIRST TRUST ADVISORS LP | DOUBLED | 118,622 | 278,340 | +134.6% | $6.5M | 2026-Q1 |
| FRANKLIN RESOURCES INC | NEAR_EXIT | 1,392,341 | 257,607 | -81.5% | $6.0M | 2026-Q1 |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | TRIM | 481,821 | 234,359 | -51.4% | $5.5M | 2026-Q1 |
| AMERIPRISE FINANCIAL INC | ADD | 144,998 | 192,799 | +33.0% | $4.5M | 2026-Q1 |
| NOMURA HOLDINGS INC | TRIM | 246,545 | 144,087 | -41.6% | $3.4M | 2026-Q1 |
| SEI INVESTMENTS CO | ADD | 87,063 | 131,205 | +50.7% | $3.1M | 2026-Q1 |
| Universal- Beteiligungs- und Servicegesellschaft mbH | TRIM | 173,119 | 115,021 | -33.6% | $2.7M | 2026-Q1 |
| HSBC HOLDINGS PLC | TRIM | 323,646 | 101,608 | -68.6% | $2.4M | 2026-Q1 |
| QRG CAPITAL MANAGEMENT, INC. | ADD | 79,704 | 101,311 | +27.1% | $2.4M | 2026-Q1 |
| JENNISON ASSOCIATES LLC | ADD | 46,403 | 69,767 | +50.4% | $1.6M | 2026-Q1 |
| FMR LLC | DOUBLED | 29,032 | 68,730 | +136.7% | $1.6M | 2026-Q1 |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | NEAR_EXIT | 330,757 | 68,000 | -79.4% | $1.6M | 2026-Q1 |
| LOS ANGELES CAPITAL MANAGEMENT LLC | NEAR_EXIT | 253,104 | 53,533 | -78.8% | $1.2M | 2026-Q1 |
| HighTower Advisors, LLC | ADD | 26,128 | 35,595 | +36.2% | $829.4K | 2026-Q1 |
| ENVESTNET ASSET MANAGEMENT INC | DOUBLED | 11,425 | 32,470 | +184.2% | $756.6K | 2026-Q1 |
| Cerity Partners LLC | ADD | 13,688 | 24,327 | +77.7% | $566.8K | 2026-Q1 |
| Amundi | TRIM | 46,824 | 21,940 | -53.1% | $511.2K | 2026-Q1 |
| FIFTH THIRD BANCORP | DOUBLED | 621 | 17,038 | +2643.6% | $397.0K | 2026-Q1 |
| Mariner, LLC | ADD | 11,662 | 15,408 | +32.1% | $359.0K | 2026-Q1 |
| CWM, LLC | ADD | 9,037 | 14,060 | +55.6% | $327.6K | 2026-Q1 |
8 unique insiders with 24 transactions. Net insider value: $0.00 ($0.00 bought, $0.00 sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| May 20, 2026 | Raifeld Pavel | Chief Executive Officer | TAX W/H | 1,130 | $22.24 | $25.1K |
| May 20, 2026 | Zhen Marianne | Chief Accounting Officer | TAX W/H | 1,127 | $22.24 | $25.1K |
| May 20, 2026 | Basso Stephen | Chief Financial Officer | TAX W/H | 559 | $22.24 | $12.4K |
| May 18, 2026 | Linden Josephine | Director | AWARD | 5,733 | — | — |
| May 18, 2026 | Linden Josephine | Director | AWARD | 9,166 | — | — |
| May 15, 2026 | Raifeld Pavel | Chief Executive Officer | AWARD | 1,123 | — | — |
| May 15, 2026 | Basso Stephen | Chief Financial Officer | AWARD | 1,123 | — | — |
| May 4, 2026 | DiPaolo Mark | Director | AWARD | 9,786 | — | — |
| May 4, 2026 | Haimovitz Jules | Director | AWARD | 9,786 | — | — |
| May 4, 2026 | Small Derek A | Director | AWARD | 10,000 | — | — |
| May 4, 2026 | Basso Stephen | Chief Financial Officer | AWARD | 93,750 | — | — |
| May 4, 2026 | Schlesinger Sarah J. | Director | AWARD | 10,000 | — | — |
| May 4, 2026 | Zhen Marianne | Chief Accounting Officer | AWARD | 31,500 | — | — |
| May 4, 2026 | Raifeld Pavel | Chief Executive Officer | AWARD | 312,500 | — | — |
| May 4, 2026 | DiPaolo Mark | Director | AWARD | 10,000 | — | — |
| May 4, 2026 | Haimovitz Jules | Director | AWARD | 10,000 | — | — |
| May 4, 2026 | Zhen Marianne | Chief Accounting Officer | AWARD | 12,766 | — | — |
| May 4, 2026 | Raifeld Pavel | Chief Executive Officer | AWARD | 126,646 | — | — |
| May 4, 2026 | Small Derek A | Director | AWARD | 9,786 | — | — |
| May 4, 2026 | Basso Stephen | Chief Financial Officer | AWARD | 37,994 | — | — |
| May 4, 2026 | Schlesinger Sarah J. | Director | AWARD | 9,786 | — | — |
| Feb 20, 2026 | Raifeld Pavel | Chief Executive Officer | TAX W/H | 2,986 | $23.39 | $69.8K |
| Feb 20, 2026 | Basso Stephen | Chief Financial Officer | TAX W/H | 1,244 | $23.39 | $29.1K |
| Feb 20, 2026 | Zhen Marianne | Chief Accounting Officer | TAX W/H | 2,460 | $23.39 | $57.5K |
3 SEC filing reports analyzed. Sentiment: 0 bullish, 0 bearish, 1 mixed, 2 neutral. Avg impact: 3.7/10.
NEUTRAL
8-K
3/10
Innoviva reported the resignations of board members Derek Small and Mark DiPaolo to focus on their r
May 18, 2026
MIXED
8-K
5/10
Innoviva reported Q1 2026 total revenue of $98.0M (+11% YoY, slightly below $101.6M consensus) and d
May 6, 2026
NEUTRAL
10-K/A
3/10
Innoviva, Inc. filed an amended 10-K to include the audited consolidated financial statements of its
Mar 27, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Current analyst consensus: Strong Buy (82% buy). Based on 11 analysts: 4 strong buy, 5 buy, 1 hold, 1 sell, 0 strong sell.
Analyst Price Targets
$35.50 mean target
+56.1% upside
Strong Buy (2.00)
$18.00 Low
$46.00 High
| Metric | Value |
|---|---|
| Current Price | $22.74 |
| Target Low | $18.00 |
| Target Mean | $35.50 |
| Target Median | $39.00 |
| Target High | $46.00 |
| # Analysts | 4 |
| Recommendation | Strong Buy (2.00) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$0.50 | $0.50 | $0.50 | — | +0.0% | 1↑ 1↓ | $0.1B | 10.7% | 1 |
| Next Q 2026-09-30 |
$0.46 | $0.46 | $0.46 | 19.6% | +0.0% | 0↑ 1↓ | $0.1B | 5.3% | 1 |
| Current FY 2026-12-31 |
$1.91 | $1.91 | $1.91 | 1.9% | +0.0% | 1↑ 1↓ | $0.4B | 7.1% | 1 |
| Next FY 2027-12-31 |
$2.21 | $2.21 | $2.21 | 15.7% | -3.3% | 0↑ 2↓ | $0.5B | 10.3% | 1 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $0.500 | |
| 7d ago | $0.500 | |
| 30d ago | $0.500 | |
| 60d ago | $0.500 | |
| 90d ago | $0.535 | -0.035 |
2 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 1 initiations.
Individual Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Jun 1, 2026 | HC Wainwright & Co. | REITERATE | Buy | Buy |
| May 26, 2026 | BTIG | REITERATE | Buy | Buy |
| May 7, 2026 | BTIG | MAINTAIN | Buy | Buy |
| Feb 26, 2026 | BTIG | REITERATE | Buy | Buy |
| Feb 17, 2026 | BTIG | INITIATE | — | Buy |
| Dec 16, 2025 | HC Wainwright & Co. | MAINTAIN | Buy | Buy |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 4 | 5 | 1 | 1 | 0 | 82% | |
| May 1, 2026 | 4 | 5 | 1 | 1 | 0 | 82% | |
| Apr 1, 2026 | 4 | 5 | 1 | 1 | 0 | 82% | |
| Mar 1, 2026 | 4 | 5 | 1 | 1 | 0 | 82% | |
| Feb 1, 2026 | 3 | 5 | 1 | 1 | 0 | 80% | |
| Jan 1, 2026 | 3 | 5 | 1 | 1 | 0 | 80% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
67°
Warm
Bearish
Neutral
Bullish
2 mentions
2 bullish
0 bearish
2 time periods
Reddit Sentiment History
| Date | Mentions | Sentiment | Bullish | Bearish | Threads |
|---|---|---|---|---|---|
| Apr 22, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
| Apr 22, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
Recent Reddit Threads
May 22, 2026
short_volume
Short Volume: INVA — 82.1% short (0.6M / 0.7M)
Short: 589,297 | Exempt: 223,800 | TRF Vol: 717,911 | Short Ratio: 82.1% | Off-exchange volume (dark pool + OTC)
May 13, 2026
earnings_calendar
INVA Q1 2026 Earnings Scheduled — 2026-05-13
May 5, 2026
earnings_calendar
INVA Q1 2026 Earnings Scheduled — 2026-05-05
Mar 4, 2026
earnings_calendar
INVA Q4 2025 Earnings After Market Close — 2026-03-04
Dec 15, 2025
fda_pdufa
PDUFA: INVA — zoliflodacin in uncomplicated gonorrhea in adults and pediatric patients 12 years and older — 2025-12-15
FDA target action date 2025-12-15 for INVA (Innoviva, Inc.). Drug: zoliflodacin. Indication: uncomplicated gonorrhea in adults and pediatric patients